Flexion Therapeutics Inc Contracts & Agreements

First Supplemental Indenture, dated as of November 19, 2021, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as trustee (Filed With SEC on November 19, 2021)

Manufacturing and Supply Agreement, dated July 31, 2015, by and between Flexion and Patheon UK Limited (Filed With SEC on November 12, 2021)

Technical Transfer and Service Agreement, dated July 31, 2015, by and between Flexion and Patheon UK Limited (Filed With SEC on November 12, 2021)

Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc., Pacira BioSciences, Inc. and Oyster Acquisition Company Inc (Filed With SEC on October 12, 2021)

Form of Tender and Support Agreement, dated as of October 11, 2021 (Filed With SEC on October 12, 2021)

Separation Agreement between Flexion and Scott Kelley, dated May 3, 2021 (Filed With SEC on August 4, 2021)

Offer Letter between Flexion and Frederick Driscoll dated May 12, 2021 (Filed With SEC on August 4, 2021)

Offer Letter between Flexion and William Andrews dated May 1, 2021 (Filed With SEC on August 4, 2021)

Second Amendment to Amended and Restated Credit and Security Agreement date July 30, 2021 (Filed With SEC on August 4, 2021)

Supply Agreement, dated November 10, 2016, between Flexion and Evonik Corporation (Filed With SEC on August 4, 2021)

Amendment No. 1 to the July 1, 2016 Supply Agreement by and between Evonik Corporation and Flexion, effective as of June 30, 2021 (Filed With SEC on August 4, 2021)

Offer Letter between Flexion and Adam Muzikant dated January 1, 2021 (Filed With SEC on March 10, 2021)

Equity Distribution Agreement dated November 4, 2020, by and among Flexion Therapeutics, Inc., Goldman Sachs & Co. LLC, and Credit Suisse Securities (USA) LLC (Filed With SEC on November 4, 2020)

Underwriting Agreement, dated May 20, 2020 (Filed With SEC on May 21, 2020)

Offer Letter between Flexion and Melissa Layman (Filed With SEC on May 7, 2020)

Side Letter to the Patheon Manufacturing and Supply Agreement dated as of April 8, 2020 (Filed With SEC on May 7, 2020)

Description of Common Stock (Filed With SEC on March 12, 2020)

Flexion Therapeutics, Inc. Non-Employee Director Compensation Policy, as revised (Filed With SEC on March 12, 2020)

Separation and Consulting Agreement between Flexion and Neil Bodick, dated December 9, 2019 (Filed With SEC on March 12, 2020)

First Amendment to the Technical Transfer and Service Agreement, dated May 12, 2019, between Flexion and Patheon UK Limited (Filed With SEC on August 6, 2019)

First Amendment to the Manufacturing and Supply Agreement, dated May 12, 2019, between Flexion and Patheon UK Limited (Filed With SEC on August 6, 2019)

Second Amendment to the Manufacturing and Supply Agreement, dated June 21, 2019, between Flexion and Patheon UK Limited (Filed With SEC on August 6, 2019)

Eighth Amendment of Lease, dated June 21, 2019, between Flexion and CIP II/RJK 10-20 BMR Owner LLC (Filed With SEC on August 6, 2019)

Amended and Restated Credit and Security Agreement dated as of August 2, 2019, by and among Flexion Therapeutics, Inc., Silicon Valley Bank as agent, MidCap Financial Trust,... (Filed With SEC on August 6, 2019)

Amended and Restated Offer Letter between Flexion and Christina Willwerth (Filed With SEC on February 28, 2019)

Offer Letter between Flexion and David Arkowitz (Filed With SEC on May 8, 2018)

Flexion Therapeutics, Inc. Non-Employee Director Compensation Policy, as revised (Filed With SEC on March 8, 2018)

Amended and Restated Offer Letter between Flexion and Scott Kelley (Filed With SEC on March 8, 2018)

Amended and Restated Offer Letter between Flexion and Mark Levine (Filed With SEC on March 8, 2018)

Amended and Restated Offer Letter between Flexion and Kerry Wentworth (Filed With SEC on March 8, 2018)

Underwriting Agreement, dated October 11, 2017 (Filed With SEC on October 12, 2017)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on August 8, 2017)

***** (Filed With SEC on August 8, 2017)

SIXTH AMENDMENT OF LEASE (Filed With SEC on May 5, 2017)

Flexion therapeutics, Inc. Non-Employee Director Compensation Policy As Revised March 15, 2017 (Filed With SEC on May 5, 2017)

FLEXION THERAPEUTICS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 2, 2017 3.375% Convertible Senior Notes due 2024 TABLE OF CONTENTS (Filed With SEC on May 2, 2017)

CONSENT AND SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on May 2, 2017)

SUPPLY AGREEMENT (Filed With SEC on March 10, 2017)

Amendment To License Agreement Between Flexion Therapeutics, Inc. And Southwest Research Institute (Filed With SEC on March 10, 2017)

Flexion Therapeutics, Inc. 3,600,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on November 16, 2016)

SIXTH AMENDMENT OF LEASE (Filed With SEC on November 7, 2016)

THIRD AMENDMENT OF LEASE (Filed With SEC on August 3, 2016)

FOURTH AMENDMENT OF LEASE (Filed With SEC on August 3, 2016)

FIFTH AMENDMENT OF LEASE (Filed With SEC on August 3, 2016)

Flexion Therapeutics, Inc. 5,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on June 8, 2016)

FLEXION THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY AS REVISED MARCH 2, 2016 (Filed With SEC on March 11, 2016)

SECOND AMENDMENT OF LEASE (Filed With SEC on March 11, 2016)

EXCLUSIVELICENSE AGREEMENT (Filed With SEC on March 11, 2016)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 9, 2015)

TECHNICAL TRANSFER AND SERVICE AGREEMENT (Filed With SEC on November 9, 2015)

FIRST AMENDMENT OF LEASE (Filed With SEC on November 9, 2015)

CREDITAND SECURITY AGREEMENT (Filed With SEC on November 9, 2015)

Flexion Therapeutics, Inc. [] Shares Common Stock ($0.001 par value) UnderwritingAgreement (Filed With SEC on December 8, 2014)

FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 12, 2014)

FLEXION THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY AS REVISED FEBRUARY 25, 2014 (Filed With SEC on March 28, 2014)

[Remainder of Page Intentionally LeftBlank] (Filed With SEC on March 28, 2014)

Flexion Therapeutics, Inc. [] Shares Common Stock ($0.001 par value) UnderwritingAgreement (Filed With SEC on January 29, 2014)

CONVERSION, AMENDMENT AND WAIVER AGREEMENT (Filed With SEC on January 29, 2014)

FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: JANUARY 27, 2014 (Filed With SEC on January 29, 2014)

FLEXION THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: JANUARY 27, 2014 (Filed With SEC on January 29, 2014)

FLEXION THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on January 29, 2014)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS AG DATE: JUNE, 12 2009 Execution Copy (Filed With SEC on January 29, 2014)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS INC DATE: 3RD SEPTEMBER, 2010 (Filed With SEC on January 29, 2014)

FLEXION THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTSAGREEMENT DECEMBER 3, 2012 FLEXION THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 8, 2014)

INDEMNITY AGREEMENT (Filed With SEC on January 8, 2014)

FLEXION THERAPEUTICS, INC. 2009 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 24, 2009 AMENDED: JANUARY 31, 2012 APPROVED BY THE STOCKHOLDERS: SEPTEMBER 29,... (Filed With SEC on January 8, 2014)

FLEXION THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 IPODATE: , 2013 (Filed With SEC on January 8, 2014)

FLEXION THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 28, 2013 APPROVED BY THESTOCKHOLDERS: , 2013 (Filed With SEC on January 8, 2014)

FLEXION THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on January 8, 2014)

Flexion Therapeutics, Inc. (Filed With SEC on January 8, 2014)

* * * (Filed With SEC on January 8, 2014)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS AG DATE: JUNE, 12 2009 Execution Copy (Filed With SEC on January 8, 2014)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and FLEXION THERAPEUTICS INC DATE: 3RD SEPTEMBER, 2010 (Filed With SEC on January 8, 2014)

CREDIT AND SECURITY AGREEMENT (Filed With SEC on January 8, 2014)

10 BURLINGTON MALL ROAD BURLINGTON, MASSACHUSETTS Lease Dated February 22, 2013 (Filed With SEC on January 8, 2014)

Category

Industry

Companies

Contracts

Flexion Therapeutics Inc Contracts & Agreements